Article Excerpt: DIADH, a partnership between the Center for Technology and Behavioral Health and the Magnuson Center for Entrepreneurship will help translate digital therapeutics and digital health innovations developed at Dartmouth into the marketplace. Registration to participate in DIADH is now open at https://www.c4tbh.org/accelerator/register. Dartmouth students, staff and faculty working to bring novel digital therapeutics and digital health tools to market will soon have a new resource available to them: the Dartmouth Innovation Accelerator for Digital Health (DIADH). The Accelerator was announced last week at “Clinically Validated Digital Therapeutics: Paths to Deployment,” an international summit hosted in Hanover by the Center for Technology and Behavioral Health (CTBH), an NIH-recognized National Center of Excellence within the Geisel School of Medicine at Dartmouth, and the Magnuson Center for Entrepreneurship at Dartmouth. The Summit brought together players from across the healthcare industry — including providers, payers, researchers, developers, regulators, and investors — for the first time to discuss the future of digital therapeutics and digital health. This is an area of healthcare that encompasses any software used to prevent, treat, or manage a medical disorder or disease. In addition, several Dartmouth faculty members who are affiliated with CTBH described the exciting work that is being at Dartmouth to bring world-class science to this important new area of healthcare. “There was a focus on problem solving and removing barriers in the industry so that we can accelerate the impact of digital health tools on people’s lives,” says Lisa A. Marsch, Ph.D., Director of CTBH.

Full Article: https://tinyurl.com/493eb29m

Article Source: Vox Daily